These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34902553)

  • 1. Computational modeling of human-nCoV protein-protein interaction network.
    Saha S; Halder AK; Bandyopadhyay SS; Chatterjee P; Nasipuri M; Basu S
    Methods; 2022 Jul; 203():488-497. PubMed ID: 34902553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of spreader nodes in human-SARS-CoV protein-protein interaction network.
    Saha S; Chatterjee P; Nasipuri M; Basu S
    PeerJ; 2021; 9():e12117. PubMed ID: 34567845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of GO-Based Protein Interaction Affinities in the Large-Scale Human-Coronavirus Family Interactome.
    Bandyopadhyay SS; Halder AK; Saha S; Chatterjee P; Nasipuri M; Basu S
    Vaccines (Basel); 2023 Feb; 11(3):. PubMed ID: 36992133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug repurposing for COVID-19 using computational screening: Is Fostamatinib/R406 a potential candidate?
    Saha S; Halder AK; Bandyopadhyay SS; Chatterjee P; Nasipuri M; Bose D; Basu S
    Methods; 2022 Jul; 203():564-574. PubMed ID: 34455072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational Identification of Human Biological Processes and Protein Sequence Motifs Putatively Targeted by SARS-CoV-2 Proteins Using Protein-Protein Interaction Networks.
    Nadeau R; Shahryari Fard S; Scheer A; Hashimoto-Roth E; Nygard D; Abramchuk I; Chung YE; Bennett SAL; Lavallée-Adam M
    J Proteome Res; 2020 Nov; 19(11):4553-4566. PubMed ID: 33103435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generic model to unravel the deeper insights of viral infections: an empirical application of evolutionary graph coloring in computational network biology.
    Kole A; Bag AK; Pal AJ; De D
    BMC Bioinformatics; 2024 Feb; 25(1):74. PubMed ID: 38365632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2.
    Zhou Y; Hou Y; Shen J; Huang Y; Martin W; Cheng F
    Cell Discov; 2020; 6():14. PubMed ID: 32194980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis.
    Chen Z; Wang C; Feng X; Nie L; Tang M; Zhang H; Xiong Y; Swisher SK; Srivastava M; Chen J
    EMBO J; 2021 Sep; 40(17):e107776. PubMed ID: 34232536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying potential drug targets and candidate drugs for COVID-19: biological networks and structural modeling approaches.
    Selvaraj G; Kaliamurthi S; Peslherbe GH; Wei DQ
    F1000Res; 2021; 10():127. PubMed ID: 33968364
    [No Abstract]   [Full Text] [Related]  

  • 10. Structural and simulation analysis of hotspot residues interactions of SARS-CoV 2 with human ACE2 receptor.
    Veeramachaneni GK; Thunuguntla VBSC; Bobbillapati J; Bondili JS
    J Biomol Struct Dyn; 2021 Jul; 39(11):4015-4025. PubMed ID: 32448098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing.
    Das AB
    BMC Med Genomics; 2021 Sep; 14(1):226. PubMed ID: 34535131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing.
    Mosharaf MP; Reza MS; Kibria MK; Ahmed FF; Kabir MH; Hasan S; Mollah MNH
    Sci Rep; 2022 Mar; 12(1):4279. PubMed ID: 35277538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting hub genes and pathways of innate immune response in COVID-19: A network biology perspective.
    Prasad K; Khatoon F; Rashid S; Ali N; AlAsmari AF; Ahmed MZ; Alqahtani AS; Alqahtani MS; Kumar V
    Int J Biol Macromol; 2020 Nov; 163():1-8. PubMed ID: 32599245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV infection crosstalk with human host cell noncoding-RNA machinery: An in-silico approach.
    Yousefi H; Poursheikhani A; Bahmanpour Z; Vatanmakanian M; Taheri M; Mashouri L; Alahari SK
    Biomed Pharmacother; 2020 Oct; 130():110548. PubMed ID: 33475497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host-Virus Chimeric Events in SARS-CoV-2-Infected Cells Are Infrequent and Artifactual.
    Yan B; Chakravorty S; Mirabelli C; Wang L; Trujillo-Ochoa JL; Chauss D; Kumar D; Lionakis MS; Olson MR; Wobus CE; Afzali B; Kazemian M
    J Virol; 2021 Jul; 95(15):e0029421. PubMed ID: 33980601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative COVID-19 biological network inference with probabilistic core decomposition.
    Guo Y; Esfahani F; Shao X; Srinivasan V; Thomo A; Xing L; Zhang X
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34791019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TMBIM6, a potential virus target protein identified by integrated multiomics data analysis in SARS-CoV-2-infected host cells.
    Han Q; Wang J; Luo H; Li L; Lu X; Liu A; Deng Y; Jiang Y
    Aging (Albany NY); 2021 Mar; 13(7):9160-9185. PubMed ID: 33744846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Host-Pathogen Interaction Analyses of SARS-CoV2 and Aspergillus fumigatus, and Pathogenesis of COVID-19-Associated Aspergillosis.
    Khan AA; Farooq F; Jain SK; Golinska P; Rai M
    Microb Ecol; 2022 Nov; 84(4):1236-1244. PubMed ID: 34738157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep Learning Based Drug Screening for Novel Coronavirus 2019-nCov.
    Zhang H; Saravanan KM; Yang Y; Hossain MT; Li J; Ren X; Pan Y; Wei Y
    Interdiscip Sci; 2020 Sep; 12(3):368-376. PubMed ID: 32488835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets.
    Zhou Y; Liu Y; Gupta S; Paramo MI; Hou Y; Mao C; Luo Y; Judd J; Wierbowski S; Bertolotti M; Nerkar M; Jehi L; Drayman N; Nicolaescu V; Gula H; Tay S; Randall G; Wang P; Lis JT; Feschotte C; Erzurum SC; Cheng F; Yu H
    Nat Biotechnol; 2023 Jan; 41(1):128-139. PubMed ID: 36217030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.